Pantosin



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Adult T-cell Lymphoma/leukaemia 33.5%
Product Used For Unknown Indication 10.6%
Constipation 9.0%
Hypertension 7.0%
Antifungal Prophylaxis 5.7%
Pneumonia 4.9%
Prophylaxis 4.3%
Schizophrenia 3.1%
Hyperlipidaemia 2.7%
Proctitis 2.7%
Stomatitis 2.7%
Gastrooesophageal Reflux Disease 2.2%
Hyperuricaemia 2.0%
Parkinson's Disease 2.0%
Hepatitis B 1.8%
Pain 1.8%
Chronic Obstructive Pulmonary Disease 1.2%
Insomnia 1.0%
Oedema Peripheral 1.0%
Senile Psychosis 1.0%
Interstitial Lung Disease 17.1%
Pneumonia 14.3%
Leukocytoclastic Vasculitis 11.4%
Shock 8.6%
Toxic Epidermal Necrolysis 5.7%
Vomiting 5.7%
White Blood Cell Count Increased 5.7%
Choking 2.9%
Intentional Drug Misuse 2.9%
Platelet Count Decreased 2.9%
Postresuscitation Encephalopathy 2.9%
Renal Disorder 2.9%
Stomatitis 2.9%
Sudden Death 2.9%
Thrombocytopenia 2.9%
Venous Aneurysm 2.9%
Verbal Abuse 2.9%
Wheelchair User 2.9%
Concomitant
Constipation 20.9%
Prophylaxis 12.3%
Product Used For Unknown Indication 9.7%
Hypertension 8.3%
Schizophrenia 7.2%
Insomnia 6.5%
Cancer Pain 6.2%
Drug Use For Unknown Indication 4.1%
Multiple Myeloma 3.7%
Rheumatoid Arthritis 3.0%
Pain 2.3%
Diabetes Mellitus 2.2%
Depression 2.2%
Infection Prophylaxis 2.1%
Adenocarcinoma Pancreas 1.9%
Gastritis 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.5%
Renal Cell Carcinoma 1.5%
Back Pain 1.4%
Nutritional Support 1.4%
White Blood Cell Count Decreased 15.1%
Interstitial Lung Disease 10.9%
Vomiting 8.0%
Platelet Count Decreased 5.9%
Pyrexia 5.0%
Rash 4.6%
Renal Disorder 4.2%
Renal Impairment 4.2%
Rhabdomyolysis 4.2%
Convulsion 3.8%
Pneumonia 3.8%
Sepsis 3.8%
Shock 3.8%
Hepatic Function Abnormal 3.4%
Intestinal Obstruction 3.4%
Neutropenia 3.4%
Renal Failure 3.4%
Thrombocytopenia 3.4%
Cerebral Haemorrhage 2.9%
Diarrhoea 2.9%